DENTSPLY SIRONA (NASDAQ:XRAY) Cut to Hold at Wall Street Zen

Wall Street Zen cut shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a buy rating to a hold rating in a research report sent to investors on Saturday.

XRAY has been the subject of several other research reports. Evercore ISI decreased their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a report on Wednesday, October 8th. Stifel Nicolaus decreased their price target on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research note on Friday, August 8th. Wells Fargo & Company lowered their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a report on Friday, August 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. Finally, UBS Group reduced their price objective on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a report on Friday, August 8th. Two analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $18.00.

DENTSPLY SIRONA Trading Up 3.4%

XRAY opened at $12.93 on Friday. The company has a fifty day moving average price of $13.39 and a two-hundred day moving average price of $14.52. DENTSPLY SIRONA has a 1-year low of $11.69 and a 1-year high of $24.86. The company has a market cap of $2.58 billion, a P/E ratio of -2.73, a price-to-earnings-growth ratio of 0.78 and a beta of 0.96. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company had revenue of $936.00 million for the quarter, compared to analysts’ expectations of $929.67 million. During the same quarter in the prior year, the firm earned $0.49 EPS. The business’s revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 10th. Stockholders of record on Friday, September 26th were issued a $0.16 dividend. The ex-dividend date was Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. DENTSPLY SIRONA’s dividend payout ratio is currently -13.50%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio boosted its holdings in shares of DENTSPLY SIRONA by 1.4% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock valued at $983,000 after buying an additional 861 shares in the last quarter. Gabelli Funds LLC lifted its position in DENTSPLY SIRONA by 1.0% during the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock valued at $1,464,000 after acquiring an additional 1,000 shares during the period. Sivia Capital Partners LLC boosted its stake in DENTSPLY SIRONA by 5.3% during the third quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock worth $327,000 after acquiring an additional 1,293 shares in the last quarter. AlphaQuest LLC grew its holdings in DENTSPLY SIRONA by 2.5% in the second quarter. AlphaQuest LLC now owns 52,817 shares of the medical instruments supplier’s stock worth $839,000 after purchasing an additional 1,294 shares during the period. Finally, Empowered Funds LLC increased its stake in shares of DENTSPLY SIRONA by 8.8% during the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after purchasing an additional 1,320 shares in the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.